Key Takeaways Spironolactone is effective for both premenopausal and postmenopausal women Finasteride is primarily used for ...
Lancet Oncol 8: 21–25 Finasteride, a type 2 5α-reductase inhibitor, is used to treat benign prostatic hyperplasia (BPH) at 5 mg daily, and male-pattern alopecia at 1 mg daily. The 5 mg regimen ...
Therefore, we randomly assigned 14 hirsute women in a 2:1 ratio to 1 of 2 treatment arms: 1) finasteride (F) treatment (n = 9; 5 mg, orally, daily), or 2) spironolactone (S) treatment (n = 5 ...
Patients received ER alfuzosin 5 mg twice daily, finasteride 5 mg daily, or both drugs for six months. Alfuzosin alone and alfuzosin-finasteride combination therapy significantly improved symptoms ...
All participants received 5 mg/day finasteride and were randomly assigned to receive either counseling on the potential sexual adverse effects of the drug or no such counseling. Using patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results